Top Markets
#1 DogBull DogBull +104.72%
#2 ADO Protocol ADO Protocol +63.10%
#3 Siacoin Siacoin +51.97%
#4 MarsCoin MarsCoin +34.95%
#5 Useless Coin Useless Coin +32.42%
#6 UnifAI Network UnifAI Network +27.31%
#7 Ontology Gas Ontology Gas +24.33%
#8 Glidr Glidr +19.86%
#9 Falcon Finance Falcon Finance +17.27%
#10 Apertum Apertum +14.71%
Coin of the day
DogBull DogBull
설정
언어
한국어
통화
USD
테마
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
주식 순위 #15973
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
주가
$15.42
시가총액
$320.83M
변동 (1일)
-1.52%
변동 (1년)
40.67%
국가
IT
거래 Newron Pharmaceuticals S.p.A. (NP5)

카테고리

Healthcare
Newron Pharmaceuticals S.p.A. (NP5)의 배당 이력
Newron Pharmaceuticals S.p.A. (주식 심볼: NP5)은 총 0회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): 0.00
배당 수익률 (TTM): 0
Newron Pharmaceuticals S.p.A. (NP5)의 2026부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
모든 배당 지급 목록
연도 배당금 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 지급
회사 배당 지급 횟수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH